Entrada Therapeutics, Inc. (TRDA)
6.77
-9.26
(-57.77%)
USD |
NASDAQ |
May 07, 14:41
Entrada Therapeutics SG&A Expense (TTM) : 41.05M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 29.83M |
| Biogen, Inc. | 2.468B |
| EyePoint, Inc. | 37.79M |
| Vertex Pharmaceuticals, Inc. | 1.357B |
| Arcutis Biotherapeutics, Inc. | 274.55M |